- Home
- CRDF vs ANGO Comparison
CRDF vs ANGO Comparison
Compare CRDF & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- ANGO
- Stock Information
- Founded
- CRDF 1999
- ANGO 1988
- Country
- CRDF United States
- ANGO United States
- Employees
- CRDF N/A
- ANGO N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- ANGO Medical/Dental Instruments
- Sector
- CRDF Health Care
- ANGO Health Care
- Exchange
- CRDF Nasdaq
- ANGO Nasdaq
- Market Cap
- CRDF 288.7M
- ANGO 401.4M
- IPO Year
- CRDF N/A
- ANGO 2004
- Fundamental
- Price
- CRDF $3.79
- ANGO $10.08
- Analyst Decision
- CRDF Strong Buy
- ANGO Strong Buy
- Analyst Count
- CRDF 4
- ANGO 3
- Target Price
- CRDF $12.00
- ANGO $13.00
- AVG Volume (30 Days)
- CRDF 1.2M
- ANGO 552.5K
- Earning Date
- CRDF 05-01-2025
- ANGO 04-02-2025
- Dividend Yield
- CRDF N/A
- ANGO N/A
- EPS Growth
- CRDF N/A
- ANGO N/A
- EPS
- CRDF N/A
- ANGO N/A
- Revenue
- CRDF $683,000.00
- ANGO $286,498,000.00
- Revenue This Year
- CRDF N/A
- ANGO N/A
- Revenue Next Year
- CRDF N/A
- ANGO $6.63
- P/E Ratio
- CRDF N/A
- ANGO N/A
- Revenue Growth
- CRDF 39.96
- ANGO N/A
- 52 Week Low
- CRDF $2.01
- ANGO $5.26
- 52 Week High
- CRDF $6.42
- ANGO $13.50
- Technical
- Relative Strength Index (RSI)
- CRDF 45.87
- ANGO 54.84
- Support Level
- CRDF $3.65
- ANGO $9.34
- Resistance Level
- CRDF $3.88
- ANGO $9.84
- Average True Range (ATR)
- CRDF 0.30
- ANGO 0.45
- MACD
- CRDF -0.03
- ANGO 0.15
- Stochastic Oscillator
- CRDF 30.00
- ANGO 96.79
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical program in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC").
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.